What is the incidence of uterine scarring following a dilation and curettage (D&C)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Uterine Scarring Following Dilation and Curettage

The incidence of uterine scarring following dilation and curettage (D&C) ranges from approximately 0.2% to 2.3%, with the risk being significantly higher in patients with pre-existing uterine abnormalities or when performed by inexperienced operators. 1

Risk Factors for Uterine Scarring After D&C

Operator Experience

  • Inexperience is a major risk factor for complications during D&C procedures
  • In a 7-year study of 11,914 D&C procedures, 23 uterine perforations occurred (0.19%), with 22 of these cases performed by trainees 1

Patient-Related Factors

  • Previous cesarean section or uterine surgery
  • Thin myometrium at the implantation site (<2 mm) increases risk of complications 2
  • Larger gestational sac or mass (≥4.5 cm) in cases of cesarean scar pregnancy 2

Types of Uterine Scarring

Uterine Perforation

  • Immediate complication occurring in approximately 0.2% of D&C procedures 1
  • May lead to bleeding, infection, and subsequent scarring

Intrauterine Adhesions (Asherman's Syndrome)

  • Formation of scar tissue within the uterine cavity
  • Can cause amenorrhea, infertility, recurrent pregnancy loss, and abnormal placentation in subsequent pregnancies

Cesarean Scar Defects

  • Particularly relevant in patients with previous cesarean deliveries
  • Prevalence of cesarean section scar defects ranges between 24% and 88% when evaluated by ultrasonography 3
  • Niche (cesarean section scar defect) prevalence varies between 56-84% using contrast-enhanced sonohysterography and 24-70% using transvaginal sonography 3

Prevention Strategies

Procedural Modifications

  • Digital dilation of the cervix during procedures may reduce abnormal scarring
  • In a study of cesarean sections, digital dilation of the internal cervical ostium significantly reduced abnormal scar formation (14.3% vs 40.6%) 4

Operator Training

  • Ensuring adequate training and supervision for those performing D&C procedures
  • Experienced operators have significantly lower complication rates 1

Monitoring and Follow-up

Post-Procedure Evaluation

  • Ultrasound evaluation 40-42 days after procedure can assess healing of the uterine tissue 4
  • Monitoring β-hCG levels after D&C for pregnancy tissue - a decrease rate of ≤66.42% on the first day after D&C is associated with persistent tissue and potential scarring 2

Special Considerations for Cesarean Scar Pregnancy

  • Ultrasound-guided D&C is recommended only when:
    • Cesarean scar is >3 mm thick
    • Blood flow around the gestational sac is not abundant
    • Maximum diameter of gestational sac is <30 mm 5
  • For high-risk cases (thin scar, large gestational sac), alternative approaches should be considered to prevent complications 5

Impact on Future Fertility

  • D&C alone versus uterine artery embolization (UAE) combined with D&C for cesarean scar pregnancy shows:
    • Longer menstrual recovery time with UAE+D&C (2.0 months vs 1.0 month)
    • Decreased menstrual blood volume in 79% of UAE+D&C patients vs 18% in D&C alone
    • However, no significant difference in subsequent pregnancy rates (75% vs 78%) or birth rates (63% vs 56%) 6

While the incidence of uterine scarring following D&C is relatively low, the consequences can be significant for future fertility and pregnancy outcomes. Proper patient selection, experienced operators, and appropriate techniques are essential to minimize these risks.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.